GANX: Gain Therapeutics, Inc. Stock

by  •  • Comments Off on GANX: Gain Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 44.56
Enterprise Value ($M) 28.11
Book Value ($M) 8.91
Book Value / Share 0.46
Price / Book 3.78
NCAV ($M) 11.13
NCAV / Share 0.44
Price / NCAV 4.00

Profitability (mra)
Return on Invested Capital (ROIC) -1.72
Return on Assets (ROA) -1.53
Return on Equity (ROE) -2.95

Liquidity (mrq)
Quick Ratio 2.84
Current Ratio 2.84

Balance Sheet (mrq) ($M)
Current Assets 13.74
Assets 14.37
Liabilities 5.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 155,039 418,455 37.05
2024-11-14 109,004 437,258 24.93
2024-11-13 56,501 222,550 25.39
2024-11-12 30,949 191,595 16.15

(click for more detail)

Similar Companies
FHTX – Foghorn Therapeutics Inc. FOLD – Amicus Therapeutics, Inc.
FULC – Fulcrum Therapeutics, Inc. GHRS – GH Research PLC
GLYC – GlycoMimetics, Inc.


Financial data and stock pages provided by
Fintel.io